0001021561-20-000077.txt : 20201215
0001021561-20-000077.hdr.sgml : 20201215
20201215170904
ACCESSION NUMBER: 0001021561-20-000077
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201215
FILED AS OF DATE: 20201215
DATE AS OF CHANGE: 20201215
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: NAPIERSKI RYAN S
CENTRAL INDEX KEY: 0001652984
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12421
FILM NUMBER: 201390306
MAIL ADDRESS:
STREET 1: C/O NU SKIN ENTERPRISES INC
STREET 2: 75 WEST CENTER STREEET
CITY: PROVO
STATE: UT
ZIP: 84601
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NU SKIN ENTERPRISES, INC.
CENTRAL INDEX KEY: 0001021561
STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
IRS NUMBER: 870565309
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 75 WEST CENTER ST
STREET 2: ATTN: GREGORY BELLISTON
CITY: PROVO
STATE: UT
ZIP: 84601
BUSINESS PHONE: 801-345-1000
MAIL ADDRESS:
STREET 1: 75 WEST CENTER ST
STREET 2: ATTN: GREGORY BELLISTON
CITY: PROVO
STATE: UT
ZIP: 84601
FORMER COMPANY:
FORMER CONFORMED NAME: NU SKIN ENTERPRISES INC
DATE OF NAME CHANGE: 19980909
FORMER COMPANY:
FORMER CONFORMED NAME: NU SKIN ASIA PACIFIC INC
DATE OF NAME CHANGE: 19960919
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2020-12-15
0001021561
NU SKIN ENTERPRISES, INC.
NUS
0001652984
NAPIERSKI RYAN S
C/O NU SKIN ENTERPRISES, INC.
75 WEST CENTER STREET
PROVO
UT
84601
0
1
0
0
President
Class A Common Stock
2020-12-07
5
G
0
3000
0
D
78500
D
Class A Common Stock
2020-12-15
4
M
0
7000
30.63
A
85500
D
Class A Common Stock
2020-12-15
4
S
0
7000
50.97
D
78500
D
Employee Stock Option (Right to Buy)
30.63
2020-12-15
4
M
0
7000
0
D
2023-03-02
Class A Common Stock
7000
77800
D
Sale pursuant to a 10b5-1 plan adopted by the Reporting Person.
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $50.85 to $51.21, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission full information regarding the number of shares sold at each separate price within this range.
Currently exercisable in full.
/s/ Gregory Belliston as Attorney-in-Fact for Ryan S. Napierski
2020-12-15